Interplay between hypercholesterolaemia and inflammation in atherosclerosis: Translating experimental targets into clinical practice
Dyslipidaemia and inflammation are closely interconnected in their contribution to atherosclerosis. In fact, low-density lipoprotein (LDL)-lowering drugs have anti-inflammatory effects. The Canakinumab Antiinflammatory Thrombosis Outcome Study (CANTOS) has shown that interleukin (IL)-1β blockade red...
Main Authors: | Tuñón, J, Bäck, M, Badimón, L, Bochaton-Piallat, M-L, Cariou, B, Daemen, MJ, Egido, J, Evans, PC, Francis, SE, Ketelhuth, DF, Lutgens, E, Matter, CM, Monaco, C, Steffens, S, Stroes, E, Vindis, C, Weber, C, Hoefer, IE |
---|---|
Format: | Journal article |
Language: | English |
Published: |
SAGE Publications
2018
|
Similar Items
-
Identifying the anti-inflammatory response to lipid lowering therapy. A position paper from the working group on Atherosclerosis and vascular biology of the European society of cardiology
by: Tunon, J, et al.
Published: (2018) -
Familial hypercholesterolaemia.
by: Gill, P, et al.
Published: (2012) -
Statins and familial hypercholesterolaemia.
by: Neil, A, et al.
Published: (2009) -
An investigation into any correlation between Single Nucleotide Polymorphism (SNP) score and Welsh score in Familial Hypercholesterolaemia patients and those with polygenic hypercholesterolaemia
by: J. Webster, et al.
Published: (2022-10-01) -
EASILY MISSED? Familial hypercholesterolaemia
by: Gill, P, et al.
Published: (2012)